Neuronetrix gets portable EEG FDA nod; JAMA wonders about Theranos;

@FierceMedDev: ICYMI yesterday: Medtronic works to boost neuromodulation with bladder control startup acquisition. Article | Follow @FierceMedDev

@VarunSaxena2: The 10 largest med tech M&A deals announced in 2014. Feature | Follow @VarunSaxena2

@EmilyWFierce: Turning to Twitter, MD Anderson doc launches campaign against cancer drug prices. Story | Follow @EmilyWFierce

> Neuronetrix got FDA clearance for clinical use of its Cognision System, which is a portable device designed for physician office use that records standard electroencephalograms (EEG) as well as auditory event-related potentials. More

> An opinion piece in The Journal of the American Medical Association (JAMA) questions why the scientific community hasn't seen any data out of the much-hyped but stealthy diagnostics company Theranos that aims to cheaply and easily diagnose diseases with only a few drops of blood. Article

> An Idaho lawmaker was schooled on the female anatomy after asking if a woman could swallow a camera to conduct a gynecological exam at a Congressional committee meeting. Story

Biotech News

@FierceBiotech: Novartis bags a surprise approval for the blood cancer-treating panobinostat. Article | Follow @FierceBiotech

@JohnCFierce: Top story yesterday: UPDATED: Bristol-Myers bags IDO immunotherapy in $1.25B buyout of fledgling Flexus. Article | Follow @JohnCFierce

@DamianFierce: MD Anderson has a Houston Rockets sponsorship called "Moon Shot of the Night," because why not. Video | Follow @DamianFierce

> Alkermes dumps its pain drug after a Phase I disappointment. Story

> Cebix hangs it up after raising $50M for diabetes drug. Article

> Shire's shopping spree continues with a buyout of rare disease biotech. Report

Pharma News

@FiercePharma: Baxter U.S. Selects Bannockburn, Ill., Facility as Location for Baxalta Global Headquarters. Release | Follow @FiercePharma

@CarlyHFierce: ICYMI: Canadian paper backpedals from Gardasil side effects story. Report | Follow @CarlyHFierce

> Baxter picks HQ for biopharma spinoff, and it's just up the road. Article

> Takeda makes an M&A move in Turkey. Report

> Actavis' buyout of Allergan could trigger $100M golden parachute for Pyott. Story

Biotech Research News

> MD Anderson team explores a combination approach against cancer metastasis. More

> Study: New antibody blocks dengue virus. Item

> UC San Diego group zeroes in on breaking a link between obesity and diabetes. Story

> Langer team offers up a hydrogel drug delivery vehicle at MIT. Report

> CRISPR project points to a new approach on Duchenne muscular dystrophy. Article

Pharma Manufacturing News

> Sun Pharma recalls epilepsy drug as dissolution woes continue. News

> Mylan bags rights to distribute Gilead's Sovaldi in India. Item

> Lupin plant hit with Form 483 but continues to rack up approvals. Report

> McKesson outed as company behind 340,000-sq-ft distribution hub in Iowa. Story

> India turns to small manufacturers for state-run generic supply biz. Article

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.